Melanoma's connections to the tumour microenvironment

Pathology

Volumn 45, Issue 5, 2013, Pages 443-452

  Brandner, Johanna M ^a   Haass, Nikolas K ^b,c,d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c CENTENARY INSTITUTE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cell cell communication; Connexins; Gap junctions; Melanoma; Tumour microenvironment

Indexed keywords

GAP JUNCTION PROTEIN;

CELL COMMUNICATION; DISEASE COURSE; HUMAN; MELANOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR MICROENVIRONMENT;

CELL COMMUNICATION; CONNEXINS; DISEASE PROGRESSION; HUMANS; MELANOMA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84887938406     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328363b3bd     Document Type: Article

References (112)

1. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1: 46-54.
2. Fitzpatrick TB, Breathnach AS. The epidermal melanin unit system. (German.) Dermatol Wochenschr 1963; 147: 481-9.
3. Jimbow K, Quevedo WC Jr, Fitzpatrick TB, et al. Some aspects of melanin biology: 1950-1975. J Invest Dermatol 1976; 67: 72-89.
4. Fitzpatrick TB, Szabo G, Seiji M, et al. Biology of the melanin pigmentary system. In: Fitzpatrick TB, Eisen A, Wolff K, et al., editors. Dermatology in General Medicine. New York: McGraw-Hill, 1979; 131-45.
5. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005; 10: 153-63.
6. Haass NK, Smalley KS, Herlyn M. The role of altered cell-cell communication in melanoma progression. J Mol Histol 2004; 35: 309-18.
7. Haass NK, Smalley KS, Li L, et al. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005; 18: 150-9.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
9. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
10. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000; 6: 324-9.
11. Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep 2008; 10: 439-46.
12. Zigler M, Kamiya T, Brantley EC, et al. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res 2011; 71: 6561-6.
13. Haass NK, Ripperger D, Wladykowski E, et al. Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment. Histochem Cell Biol 2010; 133: 113-24.
14. Groebe K, Mueller-Klieser W. Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters. Eur Biophys J 1991; 19: 169-81.
15. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006; 6: 583-92.
16. Santiago-Walker A, Li L, Haass NK, et al. Melanocytes: from morphology to application. Skin Pharmacol Physiol 2009; 22: 114-21.
17. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
18. Richard G. Connexins: a connection with the skin. Exp Dermatol 2000; 9: 77-96.
19. Maeda S, Tsukihara T. Structure of the gap junction channel and its implications for its biological functions. Cell Mol Life Sci 2011; 68: 1115-29.
20. Goldberg GS, Valiunas V, Brink PR. Selective permeability of gap junction channels. Biochim Biophys Acta 2004; 1662: 96-101.
21. Di WL, Rugg EL, Leigh IM, et al. Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol 2001; 117: 958-64.
22. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-37.
23. Zucker SN, Bancroft TA, Place DE, et al. A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties in human metastatic melanoma cells. J Cell Physiol 2013; 228: 853-9.
24. Djalilian AR, McGaughey D, Patel S, et al. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 2006; 116: 1243-53.
25. Langlois S, Maher AC, Manias JL, et al. Connexin levels regulate keratinocyte differentiation in the epidermis. J Biol Chem 2007; 282: 30171-80.
26. Maass K, Ghanem A, Kim JS, et al. Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin 43. Mol Biol Cell 2004; 15: 4597-608.
27. Man YK, Trolove C, Tattersall D, et al. A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 2007; 218: 29-37.
28. Kretz M, Maass K, Willecke K. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur J Cell Biol 2004; 83: 647-54.
29. Mese G, Richard G, White TW. Gap junctions: basic structure and function. J Invest Dermatol 2007; 127: 2516-24.
30. Hsu M, Andl T, Li G, et al. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 2000; 113: 1535-42.
31. Satyamoorthy K, Muyrers J, Meier F, et al. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 2001; 20: 4676-84.
32. Barr TP, Albrecht PJ, Hou Q, et al. Air-stimulated ATP release from keratinocytes occurs through connexin hemichannels. PLoS One 2013; 8: e56744.
33. Chandrasekhar A, Bera AK. Hemichannels: permeants and their effect on development, physiology and death. Cell Biochem Funct 2012; 30: 89-100.
34. Herve JC, Bourmeyster N, Sarrouilhe D, et al. Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 2007; 94: 29-65.
35. Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 1966; 209: 1248-9.
36. Cronier L, Crespin S, Strale PO, et al. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 2009; 11: 323-38.
37. Mesnil M, Crespin S, Avanzo JL, et al. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005; 1719: 125-45.
38. Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat Rev Cancer 2010; 10: 435-41.
39. Eghbali B, Kessler JA, Reid LM, et al. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 1991; 88: 10701-5.
40. Loewenstein WR, Rose B. The cell-cell channel in the control of growth. Semin Cell Biol 1992; 3: 59-79.
41. Krutovskikh V, Mazzoleni G, Mironov N, et al. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994; 56: 87-94.
42. Yamaoka K, Nouchi T, Tazawa J, et al. Expression of gap junction protein connexin 32 and E-cadherin in human hepatocellular carcinoma. J Hepatol 1995; 22: 536-9.
43. Uchida Y, Matsuda K, Sasahara K, et al. Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans. Gastroenterology 1995; 109: 1492-6.
44. Friedman EA, Steinberg M. Disrupted communication between latestage premalignant human colon epithelial cells by 12-O tetradecanoylphorbol-13- acetate. Cancer Res 1982; 42: 5096-105.
45. Tsai H, Werber J, Davia MO, et al. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun 1996; 227: 64-9.
46. Krutovskikh VA, Troyanovsky SM, Piccoli C, et al. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 2000; 19: 505-13.
47. King TJ, Fukushima LH, Hieber AD, et al. Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis 2000; 21: 1097-109.
48. Hanna EA, Umhauer S, Roshong SL, et al. Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis 1999; 20: 1369-73.
49. Umhauer S, Ruch RJ, Fanning J. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 2000; 182: 999-1000.
50. Jinn Y, Ichioka M, Marumo F. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett 1998; 127: 161-9.
51. Zhang ZQ, Zhang W, Wang NQ, et al. Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis 1998; 19: 1889-94.
52. Huang RP, Hossain MZ, Sehgal A, et al. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 1999; 70: 21-4.
53. Hirschi KK, Xu CE, Tsukamoto T, et al. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996; 7: 861-70.
54. Haass NK, Wladykowski E, Kief S, et al. Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis. J Histochem Cytochem 2006; 54: 171-82.
55. Tada J, Hashimoto K. Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma. J Cutan Pathol 1997; 24: 628-35.
56. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, et al. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 1992; 51: 522-9.
57. Krutovskikh VA, Piccoli C, Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 2002; 21: 1989-99.
58. Mori R, Power KT, Wang CM, et al. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 2006; 119: 5193-203.
59. Wright CS, van Steensel MA, Hodgins MB, et al. Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. Wound Repair Regen 2009; 17: 240-9.
60. Pollok S, Pfeiffer AC, Lobmann R, et al. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 2011; 15: 861-73.
61. Xu J, Nicholson BJ. The role of connexins in ear and skin physiology -functional insights from disease-associated mutations. Biochim Biophys Acta 2013; 1828: 167-78.
62. Lampe PD. Analyzing phorbol ester effects on gap junctional communication: a dramatic inhibition of assembly. J Cell Biol 1994; 127: 1895-905.
63. Trosko JE, Chang CC, Madhukar BV, et al. Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Pathobiology 1990; 58: 265-78.
64. Atkinson MM, Menko AS, Johnson RG, et al. Rapid and reversible reduction of junctional permeability in cells infected with a temperature-sensitive mutant of avian sarcoma virus. J Cell Biol 1981; 91: 573-8.
65. Duflot-Dancer A, Mesnil M, Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 1997; 15: 2151-8.
66. Dagli ML, Yamasaki H, Krutovskikh V, et al. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis 2004; 25: 483-92.
67. Avanzo JL, Mesnil M, Hernandez-Blazquez FJ, et al. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis 2004; 25: 1973-82.
68. Omori Y, Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominantnegative manner. Int J Cancer 1998; 78: 446-53.
69. Krutovskikh VA, Yamasaki H, Tsuda H, et al. Inhibition of intrinsic gapjunction intercellular communication and enhancement of tumorigenicity of the rat bladder carcinoma cell line BC31 by a dominant-negative connexin 43 mutant. Mol Carcinog 1998; 23: 254-61.
70. Shao Q, Wang H, McLachlan E, et al. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 2005; 65: 2705-11.
71. Czyz J. The stage-specific function of gap junctions during tumourigenesis. Cell Mol Biol Lett 2008; 13: 92-102.
72. Gershon E, Plaks V, Dekel N. Gap junctions in the ovary: expression, localization and function. Mol Cell Endocrinol 2008; 282: 18-25.
73. Shen Y, Khusial PR, Li X, et al. SRC utilizes Cas to block gap junctional communication mediated by connexin43. J Biol Chem 2007; 282: 18914-21.
74. Temme A, Buchmann A, Gabriel HD, et al. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32. Curr Biol 1997; 7: 713-6.
75. King TJ, Lampe PD. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res 2004; 64: 7191-6.
76. King TJ, Lampe PD. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004; 25: 669-80.
77. Moennikes O, Buchmann A, Willecke K, et al. Hepatocarcinogenesis in female mice with mosaic expression of connexin32. Hepatology 2000; 32: 501-6.
78. Zhu D, Caveney S, Kidder GM, et al. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci USA 1991; 88: 1883-7.
79. McLachlan E, Shao Q, Wang HL, et al. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 2006; 66: 9886-94.
80. Hellmann P, Grummer R, Schirrmacher K, et al. Transfection with different connexin genes alters growth and differentiation of human choriocarcinoma cells. Exp Cell Res 1999; 246: 480-90.
81. el-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 1991; 115: 1375-82.
82. el-Sabban ME, Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 1994; 14: 164-76.
83. Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 2000; 105: 1189-97.
84. Saunders MM, Seraj MJ, Li Z, et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001; 61: 1765-7.
85. Lin JH, Takano T, Cotrina ML, et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002; 22: 4302-11.
86. Miekus K, Czernik M, Sroka J, et al. Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell 2005; 97: 893-903.
87. Pollmann MA, Shao Q, Laird DW, et al. Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 2005; 7: R522-34.
88. Kanczuga-Koda L, Sulkowski S, Lenczewski A, et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006; 59: 429-33.
89. Bates DC, Sin WC, Aftab Q, et al. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 2007; 55: 1554-64.
90. Li Q, Omori Y, Nishikawa Y, et al. Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. Int J Cancer 2007; 121: 536-46.
91. Dobrowolski R, Sasse P, Schrickel JW, et al. The conditional connexin 43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet 2008; 17: 539-54.
92. Cotrina ML, Lin JH, Nedergaard M. Adhesive properties of connexin hemichannels. Glia 2008; 56: 1791-8.
93. Elzarrad MK, Haroon A, Willecke K, et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 2008; 6: 20.
94. Ezumi K, Yamamoto H, Murata K, et al. Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res 2008; 14: 677-84.
95. Lin Q, Balasubramanian K, Fan D, et al. Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia 2010; 12: 748-54.
96. Schiffner S, Zimara N, Schmid R, et al. p54nrb is a new regulator of progression of malignant melanoma. Carcinogenesis 2011; 32: 1176-82.
97. Su YA, Bittner ML, Chen Y, et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 2000; 28: 119-27.
98. Villares GJ, Dobroff AS, Wang H, et al. Overexpression of proteaseactivated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res 2009; 69: 6730-7.
99. Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis-a possible therapeutic target. Oncotarget 2011; 2: 8-17.
100. Saccheri F, Pozzi C, Avogadri F, et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2010; 2: 44-57
101. Rezze GG, Fregnani JH, Duprat J, et al. Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum Pathol 2011; 42: 409-18.
102. Sargen MR, Gormley RH, Pasha TL, et al. Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis. Am J Dermatopathol 2013; Jan 22: (Epub ahead of print).
103. Stoletov K, Strnadel J, Zardouzian E, et al. Role of connexins in metastatic breast cancer and melanoma brain colonization. J Cell Sci 2013; 126: 904-13.
104. Haass NK, Houdek P, Brandner JM, et al. Expression patterns of connexins in merkel cell carcinoma and adjacent epidermis. In: Baumann KI, Moll I, Halata Z, editors. The Merkel Cell: Structure-Development-Function-Cancerogenesis. Berlin: Springer-Verlag, 2003; 219-22.
105. Penuela S, Gehi R, Laird DW. The biochemistry and function of pannexin channels. Biochim Biophys Acta 2013; 1828: 15-22.
106. Saito-Katsuragi M, Asada H, Niizeki H, et al. Role for connexin 26 in metastasis of human malignant melanoma: communication between melanoma and endothelial cells via connexin 26. Cancer 2007; 110: 1162-72.
107. Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin 26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat 2007; 106: 11-7.
108. Haass NK, Smalley KS. Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy. Mol Diagn Ther 2009; 13: 283-96.
109. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-34.
110. McCarty MF, Bielenberg DR, Nilsson MB, et al. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res 2003; 13: 379-87.
111. Bijnsdorp IV, Rozendaal L, van Moorselaar RJ, et al. A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasis. Br J Cancer 2012; 107: 1963-8.
112. Kandouz M, Batist G. Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets 2010; 14: 681-92.